FluoroPharma Medical (FPMI) Stock Price & Analysis
FPMI Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- 600
- Average Volume (3M)
- 0
- Market Cap
- $6,852
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- $24.72K
- Total Debt (Recent Filing)
- $5.82M
- Price to Earnings (P/E)
- ―
- Beta
- 2.18
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
FPMI FAQ
What was FluoroPharma Medical’s price range in the past 12 months?
What is FluoroPharma Medical’s market cap?
When is FluoroPharma Medical’s upcoming earnings report date?
Is FluoroPharma Medical overvalued?
Does FluoroPharma Medical pay dividends?
What is FluoroPharma Medical’s EPS estimate?
How many shares outstanding does FluoroPharma Medical have?
Which hedge fund is a major shareholder of FluoroPharma Medical?
What is the TipRanks Smart Score and how is it calculated?
Company Description
FluoroPharma Medical
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Edward L. Lyons Jr.
- Employees
- 4
- Website
- www.fluoropharma.com
- Address
- 8 Hillside Avenue, Montclair, NJ, 07042, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 2 |
| Technical Analysis | 2 | 0 | 0 |
| Moving Averages | 2 | 2 | 2 |